Magnesium Citrate Constipation Randomized Trial: What the Evidence Says

Magnesium Citrate Constipation Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first

4 min read · 622 wordsReviewed August 2026
Three brown bottles of magnesium tablets on a soft pink background, ideal for health-themed content. - Evidence evidence guide for magnesium citrate constipation randomized trial
Photo by Beelith USA on Pexels · Pexels License

Quick Answer

Magnesium Citrate Constipation Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are randomized trial, so conclusions should be framed as evidence aware guidance rather than medical advice.

Key Takeaways

  • 01This page is generated only from sources stored in the Migaku evidence knowledge base.
  • 02Current evidence mix: 1 randomized trial, 1 preclinical study.
  • 03Claims should be interpreted with the source type, study design, population, and publication date in mind.
  • 04This article is educational and does not replace care from a qualified clinician.

Magnesium Citrate Constipation Randomized Trial: What the Evidence Says

Quick Answer

Magnesium Citrate Constipation Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are randomized trial, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

  • This page is generated only from sources stored in the Migaku evidence knowledge base.
  • Current evidence mix: 1 randomized trial, 1 preclinical study.
  • Claims should be interpreted with the source type, study design, population, and publication date in mind.
  • This article is educational and does not replace care from a qualified clinician.

Evidence Map

Source Evidence type Level Date Identifier
Effects of a brown rice-derived supplement on physical, cognitive and mental health among adults and the role of the gut microbiota: study protocol for a longitudinal, double-blind, randomized, placebo-controlled trial randomized trial 2 2026-04-25 10.1186/s12906-026-05384-5
Emerging treatments and current strategies for mineral, vascular, and bone disorders in chronic kidney disease preclinical study 4 2026-03-25 10.5527/wjn.v15.i1.114146

What The Sources Report

  • In the case of rice, accumulating evidence has suggested that the consumption of brown rice, which contains bran and germ and is rich in fiber, micronutrients, and phytochemicals, can improve physical health (e.g., immune function, sleep, and obesity control), cognitive health (e.g., general cognitive function and executive function), and mental health (e.g., depression and anxiety). [Takahashi Michio (2026); evidence level 2]
  • Regarding the mechanism underlying the beneficial effects of brown rice consumption, we assume that one of the important factors associated with these positive effects on health may be the change in intestinal microbial ecology caused by the consumption of brown rice. [Takahashi Michio (2026); evidence level 2]
  • Reduced kidney function in these patients leads to a range of pathological changes in mineral metabolism termed mineral and bone disorder (MBD). [Ilkun Olesya (2026); evidence level 4]
  • Indeed, high serum phosphate in patients with ESKD is associated with increased risk of all-cause and cardiovascular (CV) mortality, as well as bone fractures. [Ilkun Olesya (2026); evidence level 4]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

There is trial evidence in the current set, but population and intervention details still matter. For magnesium citrate constipation randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

  • Takahashi Michio (2026). Effects of a brown rice-derived supplement on physical, cognitive and mental health among adults and the role of the gut microbiota: study protocol for a longitudinal, double-blind, randomized, placebo-controlled trial. DOI: 10.1186/s12906-026-05384-5. PMCID: PMC13248364. PMID: 42035088. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13248364/
  • Ilkun Olesya (2026). Emerging treatments and current strategies for mineral, vascular, and bone disorders in chronic kidney disease. DOI: 10.5527/wjn.v15.i1.114146. PMCID: PMC13010344. PMID: 41884254. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13010344/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.

FAQ

Frequently Asked Questions

M

Medically reviewed

Last reviewed August 4, 2026 by Migaku Evidence Review

Related content

← All GuidesSupplement Reference →